Many pharma companies that bought electoral bonds faced regulatory actions
Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.
The Hindu ·